These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 27355528)

  • 1. Dual tumor-suppressors miR-139-5p and miR-139-3p targeting matrix metalloprotease 11 in bladder cancer.
    Yonemori M; Seki N; Yoshino H; Matsushita R; Miyamoto K; Nakagawa M; Enokida H
    Cancer Sci; 2016 Sep; 107(9):1233-42. PubMed ID: 27355528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual strands of the miR-223 duplex (miR-223-5p and miR-223-3p) inhibit cancer cell aggressiveness: targeted genes are involved in bladder cancer pathogenesis.
    Sugawara S; Yamada Y; Arai T; Okato A; Idichi T; Kato M; Koshizuka K; Ichikawa T; Seki N
    J Hum Genet; 2018 May; 63(5):657-668. PubMed ID: 29540855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of UHRF1 by dual-strand tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p): Inhibition of bladder cancer cell aggressiveness.
    Matsushita R; Yoshino H; Enokida H; Goto Y; Miyamoto K; Yonemori M; Inoguchi S; Nakagawa M; Seki N
    Oncotarget; 2016 May; 7(19):28460-87. PubMed ID: 27072587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of ITGA3 by the dual-stranded microRNA-199 family as a potential prognostic marker in bladder cancer.
    Sakaguchi T; Yoshino H; Yonemori M; Miyamoto K; Sugita S; Matsushita R; Itesako T; Tatarano S; Nakagawa M; Enokida H
    Br J Cancer; 2017 Apr; 116(8):1077-1087. PubMed ID: 28324890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour-suppressive microRNA-144-5p directly targets CCNE1/2 as potential prognostic markers in bladder cancer.
    Matsushita R; Seki N; Chiyomaru T; Inoguchi S; Ishihara T; Goto Y; Nishikawa R; Mataki H; Tatarano S; Itesako T; Nakagawa M; Enokida H
    Br J Cancer; 2015 Jul; 113(2):282-9. PubMed ID: 26057453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour-suppressive miRNA-26a-5p and miR-26b-5p inhibit cell aggressiveness by regulating PLOD2 in bladder cancer.
    Miyamoto K; Seki N; Matsushita R; Yonemori M; Yoshino H; Nakagawa M; Enokida H
    Br J Cancer; 2016 Jul; 115(3):354-63. PubMed ID: 27310702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The microRNA expression signature of bladder cancer by deep sequencing: the functional significance of the miR-195/497 cluster.
    Itesako T; Seki N; Yoshino H; Chiyomaru T; Yamasaki T; Hidaka H; Yonezawa T; Nohata N; Kinoshita T; Nakagawa M; Enokida H
    PLoS One; 2014; 9(2):e84311. PubMed ID: 24520312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogene miR-187-5p is associated with cellular proliferation, migration, invasion, apoptosis and an increased risk of recurrence in bladder cancer.
    Li Z; Lin C; Zhao L; Zhou L; Pan X; Quan J; Peng X; Li W; Li H; Xu J; Xu W; Guan X; Chen Y; Lai Y
    Biomed Pharmacother; 2018 Sep; 105():461-469. PubMed ID: 29883941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miRNA-556-3p promotes human bladder cancer proliferation, migration and invasion by negatively regulating DAB2IP expression.
    Feng C; Sun P; Hu J; Feng H; Li M; Liu G; Pan Y; Feng Y; Xu Y; Feng K; Feng Y
    Int J Oncol; 2017 Jun; 50(6):2101-2112. PubMed ID: 28440444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-188-5p and MiR-141-3p influence prognosis of bladder cancer and promote bladder cancer synergistically.
    Yang X; Wang P
    Pathol Res Pract; 2019 Nov; 215(11):152598. PubMed ID: 31562019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deep sequencing-based microRNA expression signatures in head and neck squamous cell carcinoma: dual strands of pre-miR-150 as antitumor miRNAs.
    Koshizuka K; Nohata N; Hanazawa T; Kikkawa N; Arai T; Okato A; Fukumoto I; Katada K; Okamoto Y; Seki N
    Oncotarget; 2017 May; 8(18):30288-30304. PubMed ID: 28415821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTTG1 regulated by miR-146a-3p promotes bladder cancer migration, invasion, metastasis and growth.
    Xiang W; Wu X; Huang C; Wang M; Zhao X; Luo G; Li Y; Jiang G; Xiao X; Zeng F
    Oncotarget; 2017 Jan; 8(1):664-678. PubMed ID: 27893422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invasion-related circular RNA circFNDC3B inhibits bladder cancer progression through the miR-1178-3p/G3BP2/SRC/FAK axis.
    Liu H; Bi J; Dong W; Yang M; Shi J; Jiang N; Lin T; Huang J
    Mol Cancer; 2018 Nov; 17(1):161. PubMed ID: 30458784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA-sequence-based microRNA expression signature in breast cancer: tumor-suppressive miR-101-5p regulates molecular pathogenesis.
    Toda H; Seki N; Kurozumi S; Shinden Y; Yamada Y; Nohata N; Moriya S; Idichi T; Maemura K; Fujii T; Horiguchi J; Kijima Y; Natsugoe S
    Mol Oncol; 2020 Feb; 14(2):426-446. PubMed ID: 31755218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel oncogenic function of mesoderm development candidate 1 and its regulation by MiR-574-3p in bladder cancer cell lines.
    Tatarano S; Chiyomaru T; Kawakami K; Enokida H; Yoshino H; Hidaka H; Nohata N; Yamasaki T; Gotanda T; Tachiwada T; Seki N; Nakagawa M
    Int J Oncol; 2012 Apr; 40(4):951-9. PubMed ID: 22179486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circ_0058063 regulates CDK6 to promote bladder cancer progression by sponging miR-145-5p.
    Sun M; Zhao W; Chen Z; Li M; Li S; Wu B; Bu R
    J Cell Physiol; 2019 Apr; 234(4):4812-4824. PubMed ID: 30362519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor miR-150-5p and miR-150-3p inhibit cancer cell aggressiveness by targeting SPOCK1 in head and neck squamous cell carcinoma.
    Koshizuka K; Hanazawa T; Kikkawa N; Katada K; Okato A; Arai T; Idichi T; Osako Y; Okamoto Y; Seki N
    Auris Nasus Larynx; 2018 Aug; 45(4):854-865. PubMed ID: 29233721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EHHADH contributes to cisplatin resistance through regulation by tumor-suppressive microRNAs in bladder cancer.
    Okamura S; Yoshino H; Kuroshima K; Tsuruda M; Osako Y; Sakaguchi T; Yonemori M; Yamada Y; Tatarano S; Nakagawa M; Enokida H
    BMC Cancer; 2021 Jan; 21(1):48. PubMed ID: 33430801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenic miRNA-182-5p targets Smad4 and RECK in human bladder cancer.
    Hirata H; Ueno K; Shahryari V; Tanaka Y; Tabatabai ZL; Hinoda Y; Dahiya R
    PLoS One; 2012; 7(11):e51056. PubMed ID: 23226455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-124-3p affects proliferation, migration and apoptosis of bladder cancer cells through targeting AURKA.
    Yuan Q; Sun T; Ye F; Kong W; Jin H
    Cancer Biomark; 2017; 19(1):93-101. PubMed ID: 28269755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.